Kidney disease outcomes with semaglutide versus placebo across baseline KDIGO risk categories: a post-hoc analysis of SUSTAIN 6
Publication Title
60th ERA Congress 2023
Document Type
Presentation
Publication Date
6-2023
Keywords
washington; spokane; pmrc
Clinical Institute
Kidney & Diabetes
Specialty/Research Institute
Nephrology
Specialty/Research Institute
Endocrinology
Comments
Bain SC, Bosch-Traberg H, Cherney D, Rasmussen S, Sokareva K, Khunti K, Tuttle KR